Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pivotal Therapeutics Inc.

www.pivotaltherapeutics.us

Latest From Organon USA Inc.

What Is An Acceptable Drug Discount? DOJ and Industry Disagree

Government contends a price reduction is the only discount exception to the Anti-Kickback Statute; PhRMA says this interpretation puts companies at risk of criminal liability for other discount arrangements.

Legal Issues Reimbursement

Ferring Wins In Combo Exclusivity Case; FDA Lacks 'Legitimate Reason' To Reject

Court finds FDA erred in not giving the fixed-dose combo product Prepopik five years of market exclusivity since it had awarded the exclusivity to similarly situated single-entity drug products.

Regulation Drug Review

Sugammadex Review: Has Merck Finally Put Safety Concerns To Rest?

Adequacy of data on risks of hypersensitivity/anaphylaxis and cardiac dysrhythmia with neuromuscular blockade reversal agent are focus of FDA advisory committee review.

BioPharmaceutical United States

Fertility Market Poised For Growth Spurt After Fallow Decade

Late-stage pipeline is dominated by follicle stimulating hormones, split between “biobetters” and biosimilars. Next-generation oxytocin antagonists are leading candidates for the next novel entities in infertility.

BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Pivotal Therapeutics Inc.
  • Senior Management
  • Eugene Bortoluzzi, CEO
    George Jackowski, PhD, CSO
  • Contact Info
  • Pivotal Therapeutics Inc.
    Phone: (905) 856-9797
    81 Zenway Blvd.
    Unit 10
    Woodbridge, L4H OS5
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register